Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurochem ; 159(1): 101-115, 2021 10.
Article in English | MEDLINE | ID: mdl-34263932

ABSTRACT

Naturally occurring compounds such as sesquiterpenes and sesquiterpenoids (SQTs) have been shown to modulate GABAA receptors (GABAA Rs). In this study, the modulatory potential of 11 SQTs at GABAA Rs was analyzed to characterize their potential neurotropic activity. Transfected HEK293 cells and primary hippocampal neurons were functionally investigated using electrophysiological whole-cell recordings. Significantly different effects of ß-caryophyllene and α-humulene, as well as their respective derivatives ß-caryolanol and humulol, were observed in the HEK293 cell system. In neurons, the concomitant presence of phasic and tonic GABAA R configurations accounts for differences in receptor modulation by SQTs. The in vivo presence of the γ2 and δ subunits is important for SQT modulation. While phasic GABAA receptors in hippocampal neurons exhibited significantly altered GABA-evoked current amplitudes in the presence of humulol and guaiol, negative allosteric potential at recombinantly expressed α1 ß2 γ2 receptors was only verified for humolol. Modeling and docking studies provided support for the binding of SQTs to the neurosteroid-binding site of the GABAA R localized between transmembrane segments 1 and 3 at the (+ α)-(- α) interface. In sum, differences in the modulation of GABAA R isoforms between SQTs were identified. Another finding is that our results provide an indication that nutritional digestion affects the neurotropic potential of natural compounds.


Subject(s)
GABA-A Receptor Antagonists/pharmacology , Molecular Docking Simulation/methods , Plant Extracts/pharmacology , Receptors, GABA-A/physiology , Sesquiterpenes/pharmacology , Allosteric Regulation/drug effects , Allosteric Regulation/physiology , Animals , Female , GABA-A Receptor Antagonists/chemistry , GABA-A Receptor Antagonists/isolation & purification , HEK293 Cells , Humans , Mice , Neurons/drug effects , Neurons/physiology , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Pregnancy , Receptors, GABA-A/chemistry , Sesquiterpenes/chemistry , Sesquiterpenes/isolation & purification
2.
Sci Rep ; 10(1): 10078, 2020 06 22.
Article in English | MEDLINE | ID: mdl-32572053

ABSTRACT

Brain GABAΑ receptors are ionotropic receptors belonging to the class of Cys-loop receptors and are important drug targets for the treatment of anxiety and sleep disorders. By screening a compound library (2,112 compounds) at recombinant human α4ß1δ GABAΑ receptors heterologously expressed in a HEK cell line, we identified a scaffold of spirocyclic compounds with nanomolar antagonist activity at GABAΑ receptors. The initial screening hit 2027 (IC50 of 1.03 µM) was used for analogue search resulting in 018 (IC50 of 0.088 µM). 018 was most potent at α3,4,5-subunit containing receptors, thus showing preference for forebrain-expressed extrasynaptic receptors. Schild analysis of 018 at recombinant human α4ß1δ receptors and displacement of [3H]muscimol binding in rat cortical homogenate independently confirmed a competitive profile. The antagonist profile of 018 was further validated by whole-cell patch-clamp electrophysiology, where kinetic studies revealed a slow dissociation rate and a shallow hill slope was observed. Membrane permeability studies showed that 2027 and 018 do not cross membranes, thus making the compounds less attractive for studying central GABAΑ receptors effects, but conversely more attractive as tool compounds in relation to emerging peripheral GABAΑ receptor-mediated effects of GABA e.g. in the immune system.


Subject(s)
GABA-A Receptor Antagonists/isolation & purification , GABA-A Receptor Antagonists/pharmacology , Receptors, GABA-A/metabolism , Drug Evaluation, Preclinical/methods , Electrophysiological Phenomena/drug effects , GABA-A Receptor Antagonists/classification , HEK293 Cells , Humans , Kinetics , Membrane Potentials/drug effects , Patch-Clamp Techniques , Protein Subunits/metabolism , Small Molecule Libraries/pharmacology , gamma-Aminobutyric Acid/metabolism
3.
Magn Reson Chem ; 58(6): 584-593, 2020 06.
Article in English | MEDLINE | ID: mdl-31912552

ABSTRACT

The biologically active alkaloid muscimol is present in fly agaric mushroom (Amanita muscaria), and its structure and action is related to human neurotransmitter γ -aminobutyric acid (GABA). The current study reports on determination of muscimol form present in water solution using multinuclear 1 H and 13 C nuclear magnetic resonance (NMR) experiments supported by density functional theory molecular modeling. The structures of three forms of free muscimol molecule both in the gas phase and in the presence of water solvent, modeled by polarized continuous model, and nuclear magnetic isotropic shieldings, the corresponding chemical shifts, and indirect spin-spin coupling constants were calculated. Several J-couplings observed in proton and carbon NMR spectra, not available before, are reported. The obtained experimental spectra, supported by theoretical calculations, favor the zwitterion form of muscimol in water. This structure differs from NH isomer, previously determined in dimethyl sulfoxide (DMSO) solution. In addition, positions of signals C3 and C5 are reversed in both solvents.


Subject(s)
Amanita/chemistry , GABA-A Receptor Antagonists/chemistry , Muscimol/chemistry , Water/chemistry , Carbon Isotopes , Density Functional Theory , GABA-A Receptor Antagonists/isolation & purification , GABA-A Receptor Antagonists/pharmacology , Humans , Magnetic Resonance Spectroscopy , Models, Molecular , Muscimol/isolation & purification , Muscimol/pharmacology , Protons , Receptors, GABA/metabolism
4.
SLAS Discov ; 25(5): 458-470, 2020 06.
Article in English | MEDLINE | ID: mdl-31779505

ABSTRACT

The ionotropic GABAA receptors represent the main target for different groups of widely used drugs having hypnotic and anxiolytic effects. So far, most approaches used to assess GABA activity involve invasive low -throughput electrophysiological techniques or rely on fluorescent dyes, preventing the ability to conduct noninvasive and thus nonperturbing screens. To address this limitation, we have developed an automated marker-free cell imaging method, based on digital holographic microscopy (DHM). This technology allows the automatically screening of compounds in multiple plates without having to label the cells or use special plates. This methodological approach was first validated by screening the GABAA receptor expressed in HEK cells using a selection of active compounds in agonist, antagonist, and modulator modes. Then, in a second blind screen of a library of 3041 compounds (mostly composed of natural products), 5 compounds having a specific agonist action on the GABAA receptor were identified. The hits validated from this unbiased screen were the natural products muscimol, neurosteroid alphaxalone, and three compounds belonging to the avermectin family, all known for having an agonistic effect on the GABAA receptor. The results obtained were exempt from false negatives (structurally similar unassigned hits), and false-positive hits were detected and discarded without the need for performing electrophysiological measurements. The outcome of the screen demonstrates the applicability of our screening by imaging method for the discovery of new chemical structures, particularly regarding chemicals interacting with the ionotropic GABAA receptor and more generally with any ligand-gated ion channels and transporters.


Subject(s)
GABA-A Receptor Agonists/isolation & purification , GABA-A Receptor Antagonists/isolation & purification , Molecular Imaging/methods , Receptors, GABA-A/genetics , Biological Products/chemistry , Biological Products/isolation & purification , Electrophysiological Phenomena , GABA-A Receptor Agonists/chemistry , GABA-A Receptor Antagonists/chemistry , High-Throughput Screening Assays/methods , Holography , Humans , Image Processing, Computer-Assisted/methods , Microscopy , gamma-Aminobutyric Acid/genetics , gamma-Aminobutyric Acid/metabolism
5.
Eur J Pharmacol ; 683(1-3): 35-42, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22445880

ABSTRACT

Oenanthotoxin (OETX) and dihydro-OETX are polyacetylenic diols occurring in Oenanthe crocata and are known to exert proconvulsant effects. We have recently demonstrated that these compounds downregulated GABAergic currents (Appendino et al., 2009) and that OETX induced open channel block and allosterically modulated GABA(A) receptors (Wyrembek et al., 2010). O. crocata also contains several minor OETX analogues and in the present study we tested whether their effect on GABA(A) receptors depends on the compounds' polarity. We investigated a series of five polyacetylenes characterized by a higher lipophylicity than OETX, (1-acetyl-2,3-dihydrooenanthotoxin - X1, 14-acetyloenanthotoxin-X2, 1-deoxyoenanthotoxin - X3, 14-deoxyoenanthotoxin - X4, 14-dehydro-1-deoxyOETX - X5, polarity sequence: X1>X2>X3>X4>X5). Their effects were tested first on miniature inhibitory postsynaptic currents (mIPSCs). All but X3, significantly decreased the mIPSC amplitudes while X1, X2, X4 decreased, and X3 and X5 increased the mIPSC frequency. The lack of a clear correlation between the compounds' polarity and their effect on mIPSCs might result from their presynaptic effects. We thus considered their impact on current responses to exogenous GABA applications. Amplitude reduction of current responses was most prominent for X1 and virtually absent for X5 indicating a dependence on the compound's polarity. Only X1 and X2 showed open channel block, while the kinetics of currents were affected only by X1 which further supports a dependence of the drug's effects on their polarity. In conclusion, GABA(A) receptors are inhibited and allosterically modulated by naturally occurring OETX analogues (except X5) and these effects are positively correlated with the compounds' polarity.


Subject(s)
Enediynes/chemistry , Fatty Alcohols/chemistry , GABA-A Receptor Agonists/pharmacology , GABA-A Receptor Antagonists/pharmacology , Hippocampus/drug effects , Neurons/drug effects , Polyynes/pharmacology , Synaptic Transmission/drug effects , Animals , Animals, Newborn , Anticonvulsants/chemistry , Anticonvulsants/isolation & purification , Anticonvulsants/pharmacology , Cells, Cultured , Convulsants/chemistry , Convulsants/isolation & purification , Convulsants/pharmacology , Drug Discovery , Enediynes/pharmacology , Fatty Alcohols/pharmacology , GABA-A Receptor Agonists/chemistry , GABA-A Receptor Agonists/isolation & purification , GABA-A Receptor Antagonists/chemistry , GABA-A Receptor Antagonists/isolation & purification , Hippocampus/cytology , Hippocampus/metabolism , Hydrophobic and Hydrophilic Interactions , Inhibitory Postsynaptic Potentials/drug effects , Molecular Structure , Neurons/cytology , Neurons/metabolism , Oenanthe/chemistry , Plant Roots/chemistry , Polyynes/chemistry , Polyynes/isolation & purification , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...